VistaGen Therapeutics (NASDAQ:VTGN) reported its Q3 earnings results on Thursday, February 10, 2022 at 05:00 PM.

Here's what investors need to know about the announcement.

Earnings

VistaGen Therapeutics beat estimated earnings by 28.57%, reporting an EPS of $-0.05 versus an estimate of $-0.07.

Revenue was up $44.30 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01, which was followed by a 4.0% increase in the share price the next day.

Here's a look at VistaGen Therapeutics's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.